September 11, 2014

The Food and Drug Administration approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as a chronic weight-management option. 

September 5, 2014

Purdue Pharma on Thursday shared results from several studies evaluating its investigational pain medication Hysingla ER.

September 5, 2014

Purdue Pharma on Thursday presented results from two epidemiological studies evaluating the reformulation of OxyContin. 

September 4, 2014

Clorox bleach is breaking some rules in celebration of Mercedes-Benz Fashion Week, revealing a “Cloey De La Rox” line of undies via social media platform Vine for an underwear fashion show. 

September 4, 2014

Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug. 

September 3, 2014

To help encourage early detection of diabetes in communities around the United States, Sam’s Club Pharmacy will host free diabetes screenings to both members and non-members on Sept. 13.

September 3, 2014

Teva Pharmaceutical on Wednesday announced that a positive judgment has been given by the U.K. High Court in support of Teva's case against AstraZeneca relating to the validity of EP 1,085,877 covering the SMART (Single inhaler Maintenance And Reliever Therapy) indication for AstraZeneca's fixed dose formoterol/budesonide combination product, Symbicort.

September 2, 2014

Acura Pharmaceuticals last week announced that it has been awarded a $300,000 grant by the National Institute On Drug Abuse of the National Institutes of Health to fund Phase I development of Acura's new, early stage Limitx abuse deterrent technology.

September 2, 2014

The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries — the United States, United Kingdom, France, Germany, Spain, Italy, Japan and Australia — to $23.1 billion by 2023, according to research and consulting firm GlobalData.

September 2, 2014

Sunstar Americas has introduced its new Equitance skin care to the U.S. market to give women brighter, more radiant skin starting from the inside out.

September 2, 2014

UCB on Monday announced that the Food and Drug Administration has approved a supplemental new drug application for Vimpat (lacosamide) C-V as monotherapy in the treatment of partial-onset seizures in patients with epilepsy ages 17 years and older.

September 1, 2014

The Council for Responsible Nutrition Foundation on Thursday released a report touting the important heart-healthy benefits of phytosterols — compounds found in plants that can lower cholesterol. 

September 1, 2014

Pfizer and Protalix BioTherapeutics last week announced that the Food and Drug Administration approved Elelyso (taliglucerase alfa) for injection for pediatric patients.

August 27, 2014

Low-dose aspirin lowers the occurrence of new venous blood clots — and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new study published in Monday's issue of Circulation.

August 25, 2014

ViiV Healthcare announced that the Food and Drug Administration has approved Triumeq (abacavir 600 mg, dolutegravir 50 mg and lamivudine 300 mg) tablets for the treatment of HIV-1 infection.

August 25, 2014

DSN presents a preview of some of the hottest beauty products that appear on the show floor at NACDS Total Store Expo.

August 25, 2014

DSN presents a preview of some of the hottest OTC products that appear on the show floor at NACDS Total Store Expo.

August 25, 2014

Pur Water Filtration is rolling out a new marketing campaign, the first for the brand since 2008. Taking the lead will be an eccentric character named Arthur Tweedie, who will create awareness and educate audiences about the product's filtration technology.

August 23, 2014

DSN presents a preview of some of the hottest beauty products that appear on the show floor at NACDS Total Store Expo.

August 23, 2014

DSN presents a preview of some of the hottest OTC products that appear on the show floor at NACDS Total Store Expo.

August 22, 2014

The Beauty Co. will launch its Kumiko skin care line at the NACDS TSE show in Boston on Aug. 23. The Kumiko sponge line delivers numerous benefits, the company said, and is made of natural glucomannan — which comes from the root of the Konjac plant.

August 22, 2014

The Drug Enforcement Administration issued a final rule rescheduling hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act.

August 22, 2014

Mylan on Friday announced the launch of potassium chloride extended-release tablets USP in 600-mg and 750-mg dosage strengths.

August 21, 2014

There are a number of growth drivers across the digestives space, starting with the biggest proton-pump inhibitor to make its way from behind the pharmacy bench to over-the-counter aisles since the original “Purple Pill” was switched in 2003.